scholarly journals 7 Tesla Chlorine (35Cl) and Sodium (23Na) MR Imaging of an Enchondroma

Author(s):  
Marc-André Weber ◽  
Lisa Seyler ◽  
Armin M. Nagel

We demonstrated the feasibility of 7 Tesla sodium (23Na) and chlorine (35Cl) MRI of a solitary enchondroma. For this, we established dedicated sequences on a 7-Tesla whole-body system with the following key parameters for 35Cl MRI: TE/TR = 0.35/60 ms, TRO = 5 ms, α = 90°, Δx3 = (6 mm)3, 3 averages, Tacq = 30 min and for 23Na MRI: TE/TR = 0.4/101 ms, TRO = 10ms; α = 90°; Δx3 = (1.9 mm)3, 3 averages, Tacq = 30 min 18 s. The measured apparent Na+ concentration was 255 mmol/l and was approximately 7-fold higher than the apparent Cl– concentration with about 36 mmol/l. Additionally, repeated proton MRI examinations demonstrated constant but subtle growth (≈ 0.65 ml/year) over 14 years. In conclusion, enchondromas obviously have a high contrast-to-noise ratio when compared with the normal bone marrow in 23Na and 35Cl MRI, which may contribute to detection and differentiation in unclear or subtle cases. Key Points: Citation Format

Sarcoma ◽  
1999 ◽  
Vol 3 (1) ◽  
pp. 37-41 ◽  
Author(s):  
David M. Panicek ◽  
Lawrence H. Schwartz

Knowledge of the appearances of normal bone marrow, metastases involving marrow, and therapy-related marrow changes shown by MR imaging is necessary in order to avoid misdiagnosis. This article reviews MR imaging techniques and the findings that allow distinction of normal yellow (fatty) marrow and red marrow from tumor in marrow, as well as the identification of marrow changes resulting from radiation therapy or treatment with marrow-stimulating drugs in patients with musculoskeletal tumors.


2005 ◽  
Vol 12 (9) ◽  
pp. 1190-1197 ◽  
Author(s):  
Gerhard H. Simon ◽  
Hans-Juergen Raatschen ◽  
Michael F. Wendland ◽  
Johannes von Vopelius-Feldt ◽  
Yanjun Fu ◽  
...  

Author(s):  
Bruno C. Vande Berg ◽  
P. Omoumi ◽  
C. Galant ◽  
N. Michoux ◽  
F. E. Lecouvet

2018 ◽  
Vol 2 (8) ◽  
pp. 848-858 ◽  
Author(s):  
Yelena Kovtun ◽  
Gregory E. Jones ◽  
Sharlene Adams ◽  
Lauren Harvey ◽  
Charlene A. Audette ◽  
...  

Key Points IMGN632 is a conjugate of a novel CD123-targeting antibody with a highly potent DNA alkylating payload. IMGN632 is active in preclinical models of AML with poor prognosis at concentrations far below levels that impact normal bone marrow cells.


1997 ◽  
Vol 7 (1) ◽  
pp. 241-250 ◽  
Author(s):  
Matthias Bollow ◽  
Wolfgang Knauf ◽  
Agnieszka Korfel ◽  
Matthias Taupitz ◽  
Andreas Schilling ◽  
...  

1995 ◽  
Vol 164 (4) ◽  
pp. 935-940 ◽  
Author(s):  
S H Duda ◽  
M Laniado ◽  
F Schick ◽  
M Strayle ◽  
C D Claussen

Sign in / Sign up

Export Citation Format

Share Document